ProductsBack/EPO receptor antibody

IHC-Fr analysis of human lung cancer tissue using GTX37704 EPO receptor antibody. Dilution : 2.5microg/ml

EPO receptor antibody

Name: EPO receptor antibody
SKU: GTX37704_G10
Availability: BackOrder

GTX37704

ApplicationsWestern Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen, ImmunoHistoChemistry Paraffin

Product group Antibodies

ReactivityHuman, Rat

TargetEPOR

Overview

Supplier
GeneTex
Product Name
EPO receptor antibody
Delivery Days Customer
9
Application Supplier Note
WB: 1:200-1000. IHC-P: 1:100-500. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
Applications
Western Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen, ImmunoHistoChemistry Paraffin
Certification
Research Use Only
Clonality
Polyclonal
Concentration
0.5 mg/ml
Conjugate
Unconjugated
Gene ID2057
Target name
EPOR
Target description
erythropoietin receptor
Target synonyms
EPO-R; erythropoietin receptor; truncated erythropoietin receptor
Host
Rabbit
Isotype
IgG
Protein IDP19235
Protein Name
Erythropoietin receptor
Scientific Description
This gene encodes the erythropoietin receptor which is a member of the cytokine receptor family. Upon erythropoietin binding, this receptor activates Jak2 tyrosine kinase which activates different intracellular pathways including: Ras/MAP kinase, phosphatidylinositol 3-kinase and STAT transcription factors. The stimulated erythropoietin receptor appears to have a role in erythroid cell survival. Defects in the erythropoietin receptor may produce erythroleukemia and familial erythrocytosis. Dysregulation of this gene may affect the growth of certain tumors. Alternate splicing results in multiple transcript variants.[provided by RefSeq, May 2010]
Reactivity
Human, Rat
Storage Instruction
-20°C or -80°C,2°C to 8°C
UNSPSC
12352203

Mitochondrial Metabolism as Target of the Neuroprotective Role of Erythropoietin in Parkinsons Disease. Rey F et al., 2021 Jan 15, Antioxidants (Basel)
Read more
Effects of Allicin on Pathophysiological Mechanisms during the Progression of Nephropathy Associated to Diabetes. Arellano-Buendia AS et al., 2020 Nov 15, Antioxidants (Basel)
Read more